Evidence map›Paper›PMID 32519049›Full record

ReviewClinical rheumatology2020

Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases.

Yanfeng Bao, Chen Dong, Juan Ji, Zhifeng Gu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Synergistic roles of NFATc1 and c-Jun in immunomodulation.Biochemistry and biophysics reports · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yanfeng BaoDepartment of Rheumatology, Affiliated Hospital of Nantong University, No. 20, XiSi Road, Nantong, 226001, Jiangsu Province, China.
Chen DongResearch Center of Geriatric Medicine, Affiliated Hospital of Nantong University, No. 20, XiSi Road, Nantong, 226001, Jiangsu Province, China.
Juan JiDepartment of Rheumatology, Affiliated Hospital of Nantong University, No. 20, XiSi Road, Nantong, 226001, Jiangsu Province, China. jijuan2014@126.com.
Zhifeng GuDepartment of Rheumatology, Affiliated Hospital of Nantong University, No. 20, XiSi Road, Nantong, 226001, Jiangsu Province, China. guzf@ntu.edu.cn.ORCID http://orcid.org/0000-0002-3275-0733
Nantong University · CN

Funding

National Natural Science Foundation of China 81671616National Natural Science Foundation of China 81801610National Natural Science Foundation of China 81871278Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX18_2410
6 · The paper itself

Abstract

Objective rheumatism refers to a large group of diseases with different etiology, mainly characterized by autoimmune disorder. Intestinal flora combines with the digestive organs of the human body to synthesize and secrete the key substances of growth. Several studies have reported abnormal intestinal flora in rheumatic diseases. The purposes of this research were to review the primary studies and figure out the relationship between intestinal flora and rheumatic disease activity. The article search was based on the database of PubMed (MEDLINE), EMBASE, Cochrane to collect English language studies that were published from 1985 to 2019. The articles concerning the intestinal flora and disease activities of rheumatic diseases were classified by disease types, and the relationship between disease activities and intestinal flora was summarized. Eight rheumatic diseases were included in the study. It was found that the changes of intestinal flora were significantly correlated with the activities of rheumatic diseases. There were significant differences in the classification of disease activity and the composition of intestinal flora. Interfering with the composition of intestinal flora can apparently modulate the development of disease. But how to apply such findings is rarely reported. The study finds out that intestinal flora disorder is linked to the activity of rheumatic diseases. But which specific gut flora is connected to the disease activity needs further researches. More discussion is needed on how to apply the results to clinical treatment.

Indexed as

Gastrointestinal MicrobiomeRheumatic DiseasesHumansDisease activityDysbiosisGut microbiomeRheumatic diseases

Identifiers

PMID32519049
OpenAlexW3033014166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.